http://www.capricor.com
Capricor Therapeutics, Inc. Company Intro
Capricor is Developing First-In-Class Cell and Exosome-based Therapeutics for the Treatment and prevention of Diseases
Industry
Healthcare
Capricor Therapeutics, Inc. Headquaters
8840 Wilshire Boulevard
Beverly Hills,90211
United States
Capricor Therapeutics, Inc. Share price
27 Oct 2020 01:16 GMT
$4.3900
-0.08 (-1.79 %)
Capricor Therapeutics, Inc. Market cap
$86.194 M
WMC RANKING
2020
Capricor Therapeutics, Inc. # 237
BiotechnologyLatest Capricor Therapeutics, Inc. News
26 Oct 2020
Global Duchenne Muscular Dystrophy Drugs Market 2020 ...
Key vendors/manufacturers in the market: Akashi Therapeutics Inc, Antisense ... Corp, BioMarin Pharmaceutical Inc, Biophytis SAS, Capricor Therapeutics Inc, ...
26 Oct 2020
Duchenne Muscular Dystrophy Drugs Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect
Capricor Therapeutics Inc; Catabasis Pharmaceuticals Inc; Crispr Therapeutics; Cumberland Pharmaceuticals Inc; Daiichi Sankyo Co Ltd; Debiopharm ...
26 Oct 2020
Duchenne Muscular Dystrophy Drugs Market Trend,COVID-19 ...
10.8.2 Capricor Therapeutics Inc Description, Business Overview and Total ... 10.8.3 Capricor Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales, ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Capricor Therapeutics, Inc. | 0.01 | 15.30 | 2.16 | 0 | 0 | 0 | 13.07 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.29 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 26 | 0 | 0 | 97.35 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 90.91 |
Capricor Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Capricor Therapeutics, Inc. | $600 | $9,306 | $-8,645 | $86.194M | 237 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.467B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $53.956B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.394B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.779B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Capricor Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Capricor Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
